A Shot In The Arm For Cancer Patients?

When Ernest Graf, retired president of Ben Kahn Furs in New York, was diagnosed with prostate cancer in 1993, he underwent radiation treatment. Then he opted to receive an experimental vaccine developed by Memorial Sloane-Kettering Cancer Center in New York. "I didn't want the side effects" associated with hormonal therapy, such as lethargy and diminished libido, says Graf, 79, who received four shots over 18 months. With his cancer now in remission, he credits his good health to the vaccine and to an active lifestyle that includes biking and skiing: "It strengthened my immune system without slowing me down," he says.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.